Pfizer’s Carrick in anti-smoking role

Pfizer, the world’s largest drugs company, has created a senior public policy post with special responsibility for smoking cessation products in the UK and western Europe.

Government affairs manager Ben Carrick has been promoted to the role, created just a month after the Government announced its partial ban on smoking in public spaces in England and Wales, planned for 2007.

Pfizer's over-the-counter nicotine replacement products include the Nicorette range of patches, gums and inhalators.

Carrick was unavailable for comment. A copy of his job description leaked to PRWeek reveals he will have 'a primary (but not exclusive) focus on policies that increase demand for, and improve access to, our tobacco dependence products'.

Responsibilities include strengthening 'relations in tobacco control among European governmental and non-governmental organisations and thought leaders'.

Carrick will report to  consumer health global director David Graham, based in New Jersey. Pfizer is looking for a replacement government affairs manager.

Competitors of Nicorette include GlaxoSmithKline's NiQuitin CQ range.

Pfizer's other OTC brands include Calpol, Sudafed and Benadryl.

In Ireland, a complete ban on smoking in enclosed public spaces has been in place for over a year, and in March 2006 Scotland will become the first UK country to make smoking in enclosed public places illegal.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in